What Is Pharmacogenomic Testing and Can It Help You Find the Right Medication?

If you have ever tried an antidepressant that did not work, then switched to another that caused intolerable side effects, you are not alone. For many people, finding the right psychiatric medication genuinely feels like guesswork. Or at least, it has been until recently.

Pharmacogenomic testing is a relatively new tool in private psychiatry that uses your genetic profile to help predict how your body is likely to respond to specific psychiatric medications. It will not tell you exactly which drug will cure you. But it can meaningfully reduce the trial-and-error process that makes medication management so exhausting for so many people.

At the Psyche Clinic, we offer pharmacogenomic testing as part of our commitment to personalised, evidence-informed care. This article explains what the test involves, what it can and cannot do, who it is most likely to benefit, and how it is used in practice at our clinic on Harley Street in London.

What Is Pharmacogenomics?

Pharmacogenomics, sometimes written as pharmacogenetics or abbreviated as PGx, is the study of how a person's genetic makeup influences their response to medication. The term combines pharmacology (the science of drugs) and genomics (the study of genes).

The core idea is straightforward: different people metabolise medications differently. Two individuals prescribed the same antidepressant at the same dose can have very different outcomes. One may experience relief within weeks. Another may feel no benefit at all. A third may suffer significant side effects. A large part of this variation comes down to genetics.

Pharmacogenomic testing examines specific genes that govern how your body processes psychiatric drugs. By understanding your genetic profile, your prescribing psychiatrist can make more informed decisions about which medications are more likely to be effective for you and which are more likely to cause problems.

How Does the Test Work?

The process is simpler than it sounds. At the Psyche Clinic, pharmacogenomic testing involves a straightforward cheek swab. You rub a swab on the inside of your cheek and the sample is sent to a laboratory for analysis. There are no needles, no blood tests, and no hospital admission required.

The laboratory analyses your DNA for variations in specific genes, primarily those responsible for drug metabolism. The results are returned as a clinical report, which your psychiatrist then interprets alongside your full medical history, current symptoms, and treatment goals.

The genes most commonly examined include CYP2D6 and CYP2C19, two enzymes in the cytochrome P450 system that play a central role in how the body processes many antidepressants, antipsychotics, and anxiolytics. Depending on variations in these genes, a person may be classified as a poor metaboliser, an intermediate metaboliser, a normal metaboliser, or a rapid metaboliser.

Each classification has clinical implications. A poor metaboliser processes certain drugs more slowly, meaning standard doses may accumulate to higher levels than intended and increase the risk of side effects. A rapid metaboliser clears certain drugs so quickly that standard doses may never reach therapeutically effective levels in the body, making the medication appear ineffective even when it is not.

Understanding which category you fall into can significantly change prescribing decisions.

Which Medications Does It Cover?

Pharmacogenomic testing is relevant across a wide range of psychiatric medications, including:

●       Antidepressants such as citalopram, escitalopram, sertraline, paroxetine, venlafaxine, and amitriptyline

●       Antipsychotics such as aripiprazole, risperidone, and clozapine

●       Mood stabilisers used in the treatment of bipolar disorder

●       Anxiolytics including certain benzodiazepines such as diazepam

●       ADHD medications including stimulant and non-stimulant options

The breadth of the report makes it a useful tool not only for people currently struggling to find the right antidepressant, but for anyone beginning a course of psychiatric medication who wants to reduce unnecessary trial and error from the outset.

What Does the Evidence Say?

It is important to be transparent here. Pharmacogenomic testing is a developing field and the evidence base is still evolving. It is not a magic solution. Responsible clinicians will always present it as one valuable tool among several rather than a replacement for thorough clinical assessment.

That said, there is meaningful and growing evidence to support its use in specific circumstances.

A 2024 randomised controlled trial published in the Journal of Affective Disorders found that pharmacogenomic testing-guided treatment produced significantly higher remission rates in patients with depression compared to standard care: 24% versus 15.1% at week eight, rising to 31% versus 20% by week twelve. The testing group also experienced fewer adverse drug reactions throughout the study period.

The most clinically actionable findings relate to the CYP2D6 and CYP2C19 genes, both of which have robust evidence supporting their role in predicting how individuals metabolise many commonly prescribed psychiatric medications. These genes are now recognised by leading pharmacogenomics organisations, including the Clinical Pharmacogenetics Implementation Consortium (CPIC), as clinically meaningful markers for prescribing decisions.

It is also worth noting what the test does not do. It does not predict with certainty whether a medication will work for you. Genetics is one important variable, but response to psychiatric medication is also shaped by lifestyle, concurrent medications, the specific nature of your condition, and your overall health. A pharmacogenomic report informs clinical decision-making. It does not replace it.

At the Psyche Clinic, results are always interpreted by an experienced psychiatrist within the full context of your care. The test is a clinical support tool, not a standalone verdict.

Who Is Pharmacogenomic Testing Most Likely to Benefit?

Pharmacogenomic testing is not appropriate for everyone and your psychiatrist will discuss whether it is right for your situation. It is particularly worth considering in the following circumstances.

Your current medication does not seem to be working. If you have been taking an antidepressant at an adequate dose for a sufficient period and have seen little or no improvement, a pharmacogenomic test may help explain why and point towards alternatives that your metabolism is better suited to.

You have experienced significant side effects. If you have stopped medication because the side effects were intolerable, genetic data can sometimes indicate whether that response was metabolically predictable and help identify medications less likely to produce the same problems.

You are starting psychiatric medication for the first time. Some people prefer to obtain this information at the outset so that initial prescribing decisions are informed by their genetic profile rather than made purely on the basis of population-level averages.

You are on multiple psychiatric medications. Pharmacogenomic testing can highlight potential gene-drug interactions, where a combination of medications may affect how each is metabolised and create risks that might not be immediately apparent.

You have a personal or family history of unusual medication responses. If close family members have had extreme reactions to certain drugs, there may be a genetic basis worth investigating.

What Pharmacogenomic Testing Cannot Do

In the interest of providing a complete and honest picture, there are important limitations to understand.

The test cannot predict the exact psychological or therapeutic effect of a medication on your mood, cognition, or emotional wellbeing. Genetics explains how your body processes a drug. It does not fully explain how your brain will respond to it. These are related but distinct questions.

It cannot replace a thorough psychiatric assessment. The most important foundation of any medication decision at the Psyche Clinic remains a comprehensive evaluation of your mental health history, current presentation, life circumstances, and treatment preferences. The pharmacogenomic report is one piece of a much larger clinical picture.

It is also not a diagnostic tool. It will not tell you whether you have depression, anxiety, ADHD, or any other condition. Diagnosis requires clinical assessment by a qualified psychiatrist or psychologist.

Finally, the science is still evolving. While certain gene-drug relationships have strong evidence behind them, others remain areas of active research. Your psychiatrist will be clear about which findings in your report are well-established and which should be interpreted with appropriate caution.

Pharmacogenomic Testing at the Psyche Clinic

At the Psyche Clinic, pharmacogenomic testing is available as a standalone service or as part of a broader psychiatric assessment. The test costs £1,500 and provides a comprehensive report covering a wide range of psychiatric medications.

The report is never handed to you and left unexplained. It is reviewed and interpreted by one of our experienced psychiatrists, who will walk through your results in detail, explain what they mean for your current treatment, and discuss any recommended changes in the context of your overall care plan.

Your genetic profile does not change over time. The results are yours to keep permanently and can inform prescribing decisions at any future point in your life, whether your circumstances change, you see a different clinician, or you require a new medication years from now.

To book a pharmacogenomic test or to discuss whether it might be appropriate for you, please contact us at contact@psycheclinic.co.uk or visit our appointments and pricing page.

Frequently Asked Questions

What is pharmacogenomic testing?

Pharmacogenomic testing is a genetic test conducted via a simple cheek swab that analyses specific genes involved in how your body metabolises psychiatric medications. The results help your psychiatrist make more informed decisions about which medications are most likely to be effective and well-tolerated for you specifically.

How is the test carried out?

The test involves a non-invasive cheek swab. There are no needles or blood draws required. The sample is sent to a laboratory for genetic analysis and results are returned as a clinical report that your psychiatrist reviews with you.

What does pharmacogenomic testing cost at the Psyche Clinic?

Pharmacogenomic testing at the Psyche Clinic costs £1,500. This includes laboratory analysis and a clinical review of your results with one of our psychiatrists.

Can pharmacogenomic testing tell me which antidepressant will work?

Not with certainty. The test can indicate how your body is likely to metabolise specific medications, for example whether you are likely to process a drug too quickly or too slowly. This informs prescribing decisions meaningfully, but response to antidepressants is also influenced by many other factors. It is best understood as an important clinical tool, not a definitive prediction.

Is pharmacogenomic testing available on the NHS?

Pharmacogenomic testing for psychiatric medications is not routinely available on the NHS. It is currently offered primarily in private practice settings. NHS Genomic Laboratory Hubs conduct genetic testing for a range of conditions, but routine pharmacogenomic testing for psychiatric drug selection is not yet part of standard NHS care pathways.

Who is pharmacogenomic testing most useful for?

It is particularly relevant for people who have not responded to one or more psychiatric medications, those who have experienced significant or unexpected side effects, individuals beginning psychiatric treatment who wish to reduce trial and error, and patients on multiple psychiatric medications where gene-drug interactions may be a consideration.

Will my results change over time?

No. Your genetic profile does not change throughout your life. Your pharmacogenomic results remain valid indefinitely and can be used to inform future prescribing decisions at any point, including with different clinicians or if your clinical circumstances change.

Does the test replace a psychiatric assessment?

No. Pharmacogenomic testing is a clinical support tool that works alongside a thorough psychiatric assessment, not instead of one. At the Psyche Clinic, it is always interpreted by an experienced psychiatrist within the full context of your individual history and presentation.

Is pharmacogenomic testing the same as a DNA ancestry test?

No. Ancestry tests examine a broad range of genetic markers related to heritage and family background. Pharmacogenomic testing focuses specifically on genes that govern drug metabolism and predicted medication response. They are quite different in both purpose and clinical application.

How do I find out if pharmacogenomic testing is right for me?

The best starting point is a consultation with one of our psychiatrists, who can review your history and current situation and advise whether the test is likely to be clinically useful for you. You can book via contact@psycheclinic.co.uk or through our contact page.